ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aquestive Therapeutics Inc

Aquestive Therapeutics Inc (AQST)

3,05
0,04
( 1,33% )
Mis à jour : 18:26:21

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
3,05
Prix Achat
3,04
Prix Vente
3,05
Volume échangé
816 285
2,91 Fourchette du Jour 3,05
2,24 Plage de 52 semaines 6,23
Cap du marché
Clôture Veille
3,01
Ouverture
3,04
Dernière Transaction
300
@
3.05
Dernière heure de transaction
18:26:22
Volume financier
US$ 2 422 703
VWAP
2,968
Volume moyen (3 m)
1 742 161
Actions en circulation
91 178 193
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-35,11
Bénéfice par action (BPA)
-0,09
Chiffre d'affairess
50,58M
Bénéfice net
-7,87M

À propos de Aquestive Therapeutics Inc

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Aquestive Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AQST. Le dernier cours de clôture d'Aquestive Therapeutics était de US$3,01. Au cours de la dernière année, les actions de Aquestive Therapeutics ont été négociées dans une fourchette de prix de US$ 2,24 à US$ 6,23.

Aquestive Therapeutics compte actuellement 91 178 193 actions en circulation. La capitalisation boursière d'Aquestive Therapeutics est de US$274,45 million. Aquestive Therapeutics a un ratio cours/bénéfice (ratio PE) de -35.11.

Flux d'options Aquestive Therapeutics (AQST)

Flux global

Baissier

Prime nette

-120k

Calls / Puts

0,00%

Ach. / Vent.

100,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

AQST Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.28-8.408408408413.333.372.9116980243.06328124CS
4-0.02-0.6514657980463.073.632.8720802883.21758785CS
12-2.16-41.45873320545.215.2252.8717421613.44747081CS
26-1.5-32.9670329674.555.82.8714967914.16708035CS
520.4215.9695817492.636.232.2418392833.96630587CS
1560.9746.63461538462.086.230.6189517793.10248457CS
260-1.03-25.24509803924.089.4650.6188720173.82860605CS

AQST - Frequently Asked Questions (FAQ)

What is the current Aquestive Therapeutics share price?
The current share price of Aquestive Therapeutics is US$ 3,05
How many Aquestive Therapeutics shares are in issue?
Aquestive Therapeutics has 91 178 193 shares in issue
What is the market cap of Aquestive Therapeutics?
The market capitalisation of Aquestive Therapeutics is USD 274,45M
What is the 1 year trading range for Aquestive Therapeutics share price?
Aquestive Therapeutics has traded in the range of US$ 2,24 to US$ 6,23 during the past year
What is the PE ratio of Aquestive Therapeutics?
The price to earnings ratio of Aquestive Therapeutics is -35,11
What is the cash to sales ratio of Aquestive Therapeutics?
The cash to sales ratio of Aquestive Therapeutics is 5,46
What is the reporting currency for Aquestive Therapeutics?
Aquestive Therapeutics reports financial results in USD
What is the latest annual turnover for Aquestive Therapeutics?
The latest annual turnover of Aquestive Therapeutics is USD 50,58M
What is the latest annual profit for Aquestive Therapeutics?
The latest annual profit of Aquestive Therapeutics is USD -7,87M
What is the registered address of Aquestive Therapeutics?
The registered address for Aquestive Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Aquestive Therapeutics website address?
The website address for Aquestive Therapeutics is www.aquestive.com
Which industry sector does Aquestive Therapeutics operate in?
Aquestive Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STECSantech Holdings Limited
US$ 1,66
(155,27%)
100,67M
PEPGPepGen Inc
US$ 3,03
(121,17%)
94,86M
YYAIConnexa Sports Technologies Inc
US$ 1,195
(86,69%)
112,86M
RETOReTo Eco Solutions Inc
US$ 0,7571
(86,52%)
64,35M
ATPCAgape ATP Corporation
US$ 1,48
(58,12%)
66,26M
THTarget Hospitality Corporation
US$ 4,3101
(-53,95%)
7,76M
NKLANikola Corporation
US$ 0,26015
(-31,54%)
35,27M
WDCWestern Digital Corporation
US$ 49,42
(-28,07%)
6,76M
WIMIWiMi Hologram Cloud Inc
US$ 0,9322
(-26,60%)
16,53M
STAIScanTech AI Systems Inc
US$ 2,42
(-26,44%)
3,24M
NVDANVIDIA Corporation
US$ 134,605
(0,13%)
138,85M
PLTRPalantir Technologies Inc
US$ 93,4781
(-7,77%)
119,28M
YYAIConnexa Sports Technologies Inc
US$ 1,195
(86,69%)
114,83M
CNEYCN Energy Group Inc
US$ 0,2622
(7,20%)
108,94M
STECSantech Holdings Limited
US$ 1,66
(155,27%)
101,46M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock